Dr. Sopher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
New York, NY 10032Phone+1 212-305-6559Fax+1 212-305-4778
Summary
- I am a pediatric endocrinologist with interests that include polycysytic ovary syndrome (PCOS), bone health, disorders of puberty, thyroid disorders, pituitary disorders and growth disorders. In addition to my training in pediatrics and pediatric endocrinology, I have Master of Science degrees in Nutrition and in Patient Oriented Research and have completed a research fellowship at the Body Composition Unit of Columbia University Medical Center (CUMC). My responsibilites include my clinical practice, overseeing clinical and research fellows, mentoring students, and running a clinical study. I am a certified clinical densitometrist by the International Society of Clinical Densitometry and interpret pediatric bone mineral density studies performed at CUMC. I have recently completed the TRANSFORM KL2 program sponsored by the Irving Institute of Clincal and Translational Research, a mentored career development program.
My research project, “A double-blind placebo-controlled randomized clinical trial assessing the efficacy of metformin for hepatic fat in adolescents and young adults with polycystic ovary syndrome” has the primary goal of exploring the use of novel and noninvasive testing and a pilot double-blind placebo-controlled trial of metformin with the intention of identifying and potentially treating non-alcoholic fatty liver disease in adolescents and young adults with PCOS. My research is unique in that it uses minimally invasive body composition methodology, which makes it particularly attractive for use in adolescents and young adults. My overall clinical research goal is early identification and treatment of metabolic and body composition abnormalities associated with PCOS and to prevent lifelong morbidity associated with this disorder in a young population
My training in endocrinology, body composition and nutrition gives me a distinctive perspective to patient care. I integrate my knowledge in these areas in order to best treat my patients.
Clinical Expertise
- Pediatric endocrinology, Insulin resistance, Thyroid disease, Pituitary disease, Growth disorders, Polycystic ovary syndrome
Education & Training
- Mailman School of Public Health, Columbia University Medical CenterMS, Biostatistics and Patient Oriented Research, 2012 - 2014
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 2007 - 2010
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2003 - 2006
- Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University Medical CenterMS, Nutrition, 1996 - 1999
- Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 1995 - 1996
- New York University School of MedicineClass of 1995
Certifications & Licensure
- NY State Medical License 1996 - 2026
- NJ State Medical License 1998 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
- International Society for Clinical DensitometryCertified Cllinical Densitometrist
Awards, Honors, & Recognition
- Fellow Society of Pediatric Research, 2015
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Efficacy of Vitamin D Supplementation in Obese Children Start of enrollment: 2016 Nov 30
- NAFLD in Adolescents and Young Adults With PCOS Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 156 citationsMeasurement of percentage of body fat in 411 children and adolescents: a comparison of dual-energy X-ray absorptiometry with a four-compartment model.Aviva B. Sopher, John C. Thornton, Jack Wang, Richard N. Pierson, Steven B. Heymsfield
Pediatrics. 2004-05-01 - 17 citationsOutcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective ch...Kim Shams, Tamara Cameo, Ilene Fennoy, Abeer Hassoun, Shulamit Lerner
Journal of Pediatric Endocrinology & Metabolism. 2014-07-01 - 5 citationsDistinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary Syndrome.Angie Chen-Patterson, Angelina Bernier, Tania Burgert, Vanessa Davis, Tazeena Khan
Journal of the Endocrine Society. 2024-01-05
Other
- The New MenstruationAnnalisa Merelli
https://www.statnews.com/2024/05/29/early-menarche-jama-study-average-age-first-period/
Authored Content
- Girls are going through puberty much earlier. There may be several reasons why.June 2024
Press Mentions
- Polycystic Ovary Syndrome: Clinical and Research ConsiderationsMarch 30th, 2021
- With Puberty Starting Earlier Than Ever, Doctors Urge Greater Awareness and CareJanuary 4th, 2024
- Girls Are Starting Puberty Earlier Than Ever. For Some, That Comes with Major Mental Health RisksMarch 8th, 2024
Grant Support
- A Randomized Placebo Controlled Clinical Trial of Metformin for NAFLD in Adolescents and Young Adults with PCOSNIH2013–2015
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish, French, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: